Form D · Biotechnology

Arch Oncology Investors, LLC

Portland, OR · CIK 0001861423

Offering snapshot reported May 10, 2021 · SEC filing

Reported sold
$11M
Offering amount: $11M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 10, 2021Initial$11,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-398844

Source: Form D, filed May 10, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ARCH ONCOLOGY INVESTORS, LLC

Investment adviser: 503 PARTNERS, LLC

Gross asset value
$131K
Beneficial owners
42
ADV minimum commitment
$25K

Reported in Form ADV on Oct 10, 2023. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CARTA INVESTOR SERVICES INC. SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Custodian SILICON VALLEY BANK SANTA CLARA, California, United States Related to adviser: No
Provider details
Annual audit
No
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No
Filing source

Form ADV 1792377 · Oct 10, 2023 · Schedule D 7.B.(1), fund 805-3384303922

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Anthony L Arnerich Executive
Nicholas T Walrod Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2540 Ne Martin Luther King Jr Blvd
Portland, OR, 97212